Homocysteine reduces endothelial progenitor cells in stroke patients through apoptosis

Journal of Cerebral Blood Flow and Metabolism

Volumn 29, Issue 1, 2009, Pages 157-165

  Alam, Mohammad Murshedul ^a   Mohammad, Askar A ^a   Shuaib, Umar ^a   Wang, Chenxu ^a   Ghani, Usman ^a   Schwindt, Brenda ^a   Todd, Kathryn G ^a   Shuaib, Ashfaq ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Apoptosis; B vitamins; Endothelial progenitor cells; Homocysteine; Stroke

Indexed keywords

CASPASE 3; CASPASE 8; CYTOCHROME C; HOMOCYSTEINE; PYRIDOXINE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYPERHOMOCYSTEINEMIA; PRIORITY JOURNAL; RISK FACTOR; STEM CELL; STROKE;

APOPTOSIS; CASPASE 3; CASPASE 8; CELLS, CULTURED; CYTOCHROMES C; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; RISK FACTORS; STEM CELLS; STROKE; VITAMINS;

EID: 58149173384     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2008.99     Document Type: Article

References (44)

1. Asahara T (2003) Endothelial progenitor cells for neovascularization. Ernst Schering Res Found Workshop 211-6
2. Asahara T, Isner JM (2002) Endothelial progenitor cells for vascular regeneration. J Hematother Stem Cell Res 11:171-8
3. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM (1999a) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-8
4. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM (1999b) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18:3964-72
5. Chen JZ, Zhu JH, Wang XX, Zhu JH, Xie XD, Sun J, Shang YP, Guo XG, Dai HM, Hu SJ (2004) Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J Mol Cell Cardiol 36:233-9
6. Dawson H, Collins G, Pyle R, Deep-Dixit V, Taub DD (2004) The immunoregulatory effects of homocysteine and its intermediates on T-lymphocyte function. Mech Ageing Dev 125:107-10
7. Doyle B, Metharom P, Caplice NM (2006) Endothelial progenitor cells. Endothelium 13:403-10
8. Dudman NP, Temple SE, Guo XW, Fu W, Perry MA (1999) Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo. Circ Res 84:409-16
9. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM (1993) Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb 13:1327-33
10. Ghani U, Shuaib A, Salam A, Nasir A, Shuaib U, Jeerakathil T, Sher F, O'Rourke F, Nasser AM, Schwindt B, Todd K (2005) Endothelial progenitor cells during cerebrovascular disease. Stroke 36:151-3
11. Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L, Girardi L, Yurt R, Himel H, Rafii S (2001) Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 88:167-74
12. Hackam DG, Anand SS (2003) Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA 290:932-40
13. Harpel PC, Chang VT, Borth W (1992) Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism. Proc Natl Acad Sci USA 89:10193-7
14. Haynes WG (2002) Hyperhomocysteinemia, vascular function and atherosclerosis: effects of vitamins. Cardiovasc Drugs Ther 16:391-9
15. Hess DC, Hill WD, Martin-Studdard A, Carroll J, Brailer J, Carothers J (2002) Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke. Stroke 33:1362-8
16. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593-600
17. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG (1999) Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 100:1161-8
18. Kang SS, Passen EL, Ruggie N, Wong PW, Sora H (1993) Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation 88:1463-9
19. Kang SS, Wong PW, Malinow MR (1992) Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 12:279-98
20. Kaplan ED (2003) Association between homocyst(e)ine levels and risk of vascular events. Drugs Today (Barc) 39:175-92
21. Lapergue B, Mohammad A, Shuaib A (2007) Endothelial progenitor cells and cerebrovascular diseases. Prog Neurobiol 83:349-62
22. Mazumder S, Plesca D, Almasan A (2008) Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol 414:13-21
23. McCully KS (1996) Homocysteine and vascular disease. Nat Med 2:386-9
24. Nagata S, Golstein P (1995) The Fas death factor. Science 267:1449-56
25. Noor R, Shuaib U, Wang CX, Todd K, Ghani U, Schwindt B, Shuaib A (2007) High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis. Atherosclerosis 192:92-9
26. Perna AF, Ingrosso D, Lombardi C, Acanfora F, Satta E, Cesare CM, Violetti E, Romano MM, De Santo NG (2003) Possible mechanisms of homocysteine toxicity. Kidney Int Suppl S137-40
27. Probstfield JL, Byington RP, Egan DA, Espeland MA, Margitic SE, Riley WA, Jr, Furberg CD (1993) Methodological issues facing studies of atherosclerotic change. Circulation 87:II74-81
28. Purhonen S, Palm J, Rossi D, Kaskenpaa N, Rajantie I, Yla-Herttuala S, Alitalo K, Weissman IL, Salven P (2008) Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci USA 105:6620-5
29. Rasmussen K, Moller J (2000) Total homocysteine measurement in clinical practice. Ann Clin Biochem 37(Part 5):627-48
30. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, Johnston C, Engbaek F, Schneede J, McPartlin C, Scott JM (2004) Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 50:3-32
31. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693-8
32. Southern FN, Cruz N, Fink LM, Cooney CA, Barone GW, Eidt JF, Moursi MM (1998) Hyperhomocysteinemia increases intimal hyperplasia in a rat carotid endarterectomy model. J Vasc Surg 28:909-18
33. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91:308-18
34. Stampfer MJ, Malinow MR (1995) Can lowering homocysteine levels reduce cardiovascular risk? N Engl J Med 332:328-9
35. Targonski PV, Bonetti PO, Pumper GM, Higano ST, Holmes DR, Jr, Lerman A (2003) Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation 107:2805-2809
36. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:E1-7
37. Verma S, Anderson TJ (2002) Fundamentals of endothelial function for the clinical cardiologist. Circulation 105:546-9
38. Wald DS, Law M, Morris JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325:1202
39. Weiss N, Heydrick SJ, Postea O, Keller C, Keaney JF, Jr, Loscalzo J (2003) Influence of hyperhomocysteinemia on the cellular redox state - impact on homocysteine-induced endothelial dysfunction. Clin Chem Lab Med 41:1455-61
40. Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338:1042-50
41. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, Nickenig G (2003) Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93:e17-24
42. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-82
43. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-32
44. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109:1801-9